ISTAPCA (855 views)
Fondo Europeo Pesca (269 views)
INMiND (930 views)
PRIN (1031 views)
eHealthNet (854 views)
Ponrec (810 views)
MFAG Grant (877 views)
Welcome to the Institute of Biostructure and Bioimaging (IBB) of the National Research Council of Italy (CNR).
The Institute of Biostructure and Bioimaging, with its headquarters in Naples and locations in Catania, Rome and Turin is a translational research centre that utilizes knowledge on the biological basis of diseases, and on proteins implicated in human diseases to develop new tools for prevention, diagnosis, and more targeted therapies. To accomplish the mission, there are more than 70 researchers with expertise in medicine, biology, chemistry, physics and computer science. The researchers studying biomolecules from a structural/functional standpoint, interface with clinical scientists and experts in preclinical/clinical in vivo imaging who investigate models of diseases in animals and subsequently diseases in humans.
The research activity includes basic research, pre-clinical small animals laboratories and clinical research areas.
The Institute is part of the italian node of the European Strategy Forum on Research Infrastructures that provide open user access to a complete range of state-of-the-art imaging technologies in biological, molecular and medical imaging for life scientists in Europe and beyond.
The institute is characterized by many specific skills and activities of the institution is basically made up of the following research areas:
The IBB is well equipped in terms of chemical (synthesis and analytical characterisation), biological and imaging laboratories [Cell culture / Cell microscopy / Histology, Chemistry laboratory for synthesis and characterizazion of probes for the different imaging modalities, Image analysis, Animal house (µ)PET/SPECT, (µ)MRI/MRS (low & high field), Optical Imaging, µ-CT, µ-US, Hybrid modalities (CT/PET)]
Marcello Mancini, IBB Director
Last modified by Marco Comerci on Monday 27 June 2016, 15:09:43
Positions Archive>>> (684 views)
I SEMINARI DELL'IBBMartedì 18 luglio 2017 ore 14:00Small Molecule Screeningagainst EphA2-Sam:a route to discoverpotential anticancer agents?(37 views)
Meetings Archive>>> (434 views)